Berlin - Delayed Quote EUR

Beximco Pharmaceuticals Ltd (R2WA.BE)

Compare
0.4080 0.0000 (0.00%)
At close: December 27 at 8:08:17 AM GMT+1
Loading Chart for R2WA.BE
DELL
  • Previous Close 0.4080
  • Open 0.4080
  • Bid --
  • Ask --
  • Day's Range 0.4080 - 0.4080
  • 52 Week Range 0.2320 - 0.4600
  • Volume 0
  • Avg. Volume 0
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date Jan 28, 2025 - Feb 3, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: R2WA.BE

View More

Performance Overview: R2WA.BE

Trailing total returns as of 12/28/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

R2WA.BE
1.72%
MSCI WORLD
18.50%

1-Year Return

R2WA.BE
2.65%
MSCI WORLD
18.25%

3-Year Return

R2WA.BE
59.10%
MSCI WORLD
15.99%

5-Year Return

R2WA.BE
15.35%
MSCI WORLD
58.80%

Compare To: R2WA.BE

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: R2WA.BE

View More

Valuation Measures

As of 12/23/2024
  • Market Cap

    287.98M

  • Enterprise Value

    316.66M

  • Trailing P/E

    3.86

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.51

  • Price/Book (mrq)

    0.46

  • Enterprise Value/Revenue

    0.89

  • Enterprise Value/EBITDA

    4.57

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: R2WA.BE

View More